FDA OKs First Dispersible Form of Dolutegravir for Infants FDA OKs First Dispersible Form of Dolutegravir for Infants

The FDA has also expanded the use of the already approved dolutegravir (Tivicay) 50-mg film-coated tablets for children with HIV who weigh 20 kg or more.FDA Approvals
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news